Vienna, Austria,
2023-04-06 12:52
(176 d 16:11 ago)

Posting: # 23522
Views: 2,685

 BioBridges 2023 [Conferences / Workshops]

[image]Dear all,

reserve the days for BioBridges 2023 (September 21/22, Institute of Physiology, First Faculty of Medicine, Charles Uni­ver­sity, Albertov 5, Prague 2, Czech Republic).*

Main topics:
  • M13 update on comments
  • RWE/RWD – real-world evidence / real-world data
  • Product specific GDLs
  • Clinical pharmacology and pharmacokinetics: questions and answers
  • Comparison of individual excipients, BCS-based biowaivers, questions from Agencies
  • Well Established Use (10a) – back to roots
  • Guideline on drug interaction – impact on FDCs
  • Complex formulations/products (e.g., lanreotide, amphotericin B)
  • Biosimilars – where we go in future (e.g., fast-acting insulin, GLP1)

Kind regards,
Jean-Michel Cardot, Vít Perlík, Helmut Schütz, and Ondřej Slanař for the
BioBridges Workshop Team [image] [image] [image] [image]

  • The venue is 70 m across the street from the one of previous conferences (Institute of Pharmacology, Albertov 4;
    lower left corner in the map).

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
 Admin contact
22,763 posts in 4,775 threads, 1,627 registered users;
20 visitors (0 registered, 20 guests [including 8 identified bots]).
Forum time: 05:03 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz